Almost $1 Billion Later, the US Still Can’t Manufacture Medical Gloves
Summary
Bloomberg’s Anna Edney reports on the failed U.S. effort to reshore nitrile medical glove manufacturing since the pandemic. Despite $850 million in government contracts, domestic production stalled due to high costs and reliance on Chinese raw materials. Current geopolitical tensions threaten supply chains, highlighting the challenges of sustaining American manufacturing without long-term subsidies.
Topics discussed
Ad breaks: IBM AI, UnitedHealthcare, and Samsung Galaxy Z Fold 8
Introduction: The U.S. reliance on imported nitrile medical gloves
Why domestic glove manufacturing failed after the COVID pandemic
Ad breaks: Samsung Galaxy Z Fold 8, Starbucks, and LifeMD
Case study: Blue Star NBR's failed factory and funding disputes
Government efforts to support domestic glove buyers and subsidies
Current supply chain risks due to war and raw material costs
Outro and final ad breaks: Hotels.com, Shingles vaccine, Walmart
Listen ad-free on Castria